Designed to set a new standard for procedural predictability across all ablation cases, each device brings meaningfully transformative innovation backed by seamless clinical partnership into the EP Lab, enabling electrophysiologists to optimize clinical workflows and outcomes with clear peace of mind.
FUTURE TECHNOLOGY
Optimized cardiac PFA therapy with an added design goal of a simplified user experience, FARAPULSE aims to address variable patient PV anatomy for reproducible procedures.
The VersaCross Platform is a suite of exchangeless transseptal access solutions with dedicated RF puncture technology for access-to-delivery of left heart ablation devices.
POLARx FIT is the only dual-diameter cryoballoon engineered to improve occlusion and treat more pulmonary vein anatomies.
FUTURE TECHNOLOGY
The design goals of STABLEPOINT are to combine a contact force catheter with the dynamic feedback of local impedance via DIRECTSENSE™ Technology for a full understanding of relevant cardiac tissue properties—before, during and after delivery of RF ablation.
Equipped with industry-defining tools that intelligently capture and annotate high-fidelity EGM signals, RHYTHMIA HDx offers a more complete understanding of the electrical circuit—and revealing what other systems can’t.
Sign up for our mailing list to stay up to date on all our latest breakthroughs, product releases, clinical updates and more.
Indications, Safety and Warnings:
VersaCross RF Transseptal Solutions
POLARx FIT Cryoablation Balloon Catheter
RHYTHMIA HDx Mapping System
